A Year in Review: Successes and Insights from the 2023 Global Startup Acceleration Program

Explore the achievements and lessons learned from the 2023 Global Startup Acceleration Program, showcasing how our partnership with JETRO supports Japanese startups.

The past year has been transformative for startups participating in the 2023 Global Startup Acceleration Program (GSAP). In collaboration with the Japan External Trade Organization (JETRO), GSAP has empowered numerous Japanese startups in the bio and healthcare sectors to scale their innovations and expand globally. This comprehensive review highlights the program’s successes, the invaluable insights gained, and the pivotal role of Gacsym Ventures in driving startup acceleration.

Celebrating Success: Spotlight on GSAP 2023 Cohort

GSAP 2023 brought together a diverse group of startups, each making significant strides in their respective fields. Here are some of the standout achievements from our cohort:

AMI: Revolutionizing Cardiac Screening with AI

Dr. Ogawa, a clinical cardiologist, founded AMI to address the critical need for early cardiac diagnosis. Leveraging AI technology, AMI developed an innovative stethoscope that enhances cardiac screening accuracy. In 2024, AMI showcased their advancements at major medical exhibitions such as Medical Fair Asia and the Annual Meeting of the Japanese Society for Dialysis Therapy. Their participation in international acceleration programs culminated in the launch of Cloud ChouShin®︎, a service providing analytical support for doctors in cardiac screening.

Any-Edge: Pioneering IoT Solutions for Oral Health

Any-Edge is at the forefront of IoT healthcare technology, developing home and pet sensors that monitor oral health in real-time. By utilizing non-invasive saliva and breath samples, they enable the early detection of gum disease through active inflammation biomarkers. Post-GSAP, Any-Edge was selected for the L&R Accelerator Program and the Scaler8 Kickstarter program, setting their sights on expanding into the European market.

BiPSEE: Advancing Mental Health with VR Therapeutics

Addressing the global mental health crisis, BiPSEE is crafting VR-based therapeutic solutions targeting depression, a condition affecting over 280 million people worldwide. Their SaMD (Software as a Medical Device) integrates personalized cognitive behavioral therapy (CBT) into immersive VR experiences. In 2024, BiPSEE received priority review designation from Japan’s Ministry of Health, Labour and Welfare and secured a sales and manufacturing license. Upcoming collaborations with pharmaceutical companies position BiPSEE to make significant impacts in mental health treatment.

FerroptoCure: Innovating Cancer Treatment Mechanisms

FerroptoCure is dedicated to developing anticancer agents that target the ferroptosis regulatory mechanism, a universal pathway for cellular death in cancer. The year saw FerroptoCure garner multiple awards and participate in esteemed acceleration programs like LINK-J UNIKORN and Aichi Deeptech Launchpad. With Phase 1 trials initiated in Japan and plans for clinical trials in the USA, FerroptoCure is on a promising trajectory towards groundbreaking cancer treatments.

Flying Cell: Enhancing Osteoarthritis Treatments

Focused on creating effective yet gentle treatments for osteoarthritis, Flying Cell is utilizing magnetic targeting therapy developed by Hiroshima University’s Department of Orthopedics. After completing domestic clinical trials, they are analyzing results with intentions to conduct further trials and attain approvals in major markets, including the US, to leverage established infrastructure for regenerative medicine.

iXgene: Pioneering Genome Editing for Intractable Diseases

Founded by Dr. Furukawa, Dr. Toda, Dr. Okano, and Dr. Mizuno, iXgene aims to cure intractable diseases through genome editing and iPS cell technology. By generating neural stem cells (NSCs) from iPS cells, they address critical cell sourcing challenges. In 2024, iXgene joined the LINK-J UNIKORN acceleration program and earned second place at the ICC Fukuoka 2024 Real Tech Catapult. Dr. Mizuno’s upcoming participation in the Direct Flight Philadelphia program underscores the global expansion and impact of iXgene’s innovations.

Insights and Lessons Learned from GSAP 2023

The 2023 GSAP cohort has provided invaluable lessons that will shape future acceleration programs:

• Tailored Mentorship: Personalized guidance from industry experts significantly enhances startups’ ability to navigate complex market landscapes and refine their business strategies.
• Global Expansion Support: Facilitating international exposure through exhibitions and global acceleration programs is crucial for startups aiming to scale beyond their domestic markets.
• Innovative Technology Integration: Encouraging the adoption of cutting-edge technologies, such as AI and VR, empowers startups to develop unique solutions that address pressing global challenges.
• Collaborative Ecosystem: Building strong partnerships with organizations like JETRO and leveraging networks of investors and mentors fosters a supportive environment for sustained growth.

The Impact of Startup Acceleration Programs

Startup acceleration programs like GSAP play a pivotal role in the growth and sustainability of early-stage startups. The structured support, encompassing technical evaluations, MVP development, and strategic growth planning, equips entrepreneurs with the necessary tools to transform innovative ideas into viable market products. Moreover, access to a robust network of investors and industry experts facilitates crucial funding opportunities and mentorship, addressing common barriers faced by emerging startups.

Choosing the Right Startup Accelerator

Selecting the appropriate acceleration program is vital for a startup’s success. When evaluating potential accelerators, consider the following factors:

• Expertise and Track Record: Look for programs with a proven history of scaling startups in your industry.
• Comprehensive Support: Ensure the program offers a holistic approach, including technical development, business strategy, and funding support.
• Network Access: A strong network of investors, mentors, and strategic partners can provide invaluable resources and opportunities.
• Tailored Mentorship: Personalized guidance aligned with your startup’s unique challenges and goals enhances the effectiveness of the support provided.

Moving Forward with Gacsym Ventures

Gacsym Ventures remains committed to revolutionizing startup acceleration through its structured six-step program. By continuously adapting to market demands and fostering strategic partnerships, Gacsym Ventures empowers startups to achieve sustainable growth and market readiness. Our dedication to supporting innovation not only drives economic diversification but also contributes to global advancements in technology and healthcare.

Are you an emerging entrepreneur ready to scale your startup? Join us at Gacsym Ventures and accelerate your journey to success.